NCIt definition : Genetically modified, autologous T-lymphocytes transduced with a retroviral vector
encoding a chimeric antigen receptor (CAR) specific for the tumor-associated antigen
(TAA) Lewis-Y (LeY), with potential immunomodulating and antineoplastic activities.
Upon intravenous administration, anti-LeY-CAR-transduced autologous T-lymphocytes
specifically target and induce selective toxicity in LeY-expressing tumor cells. LeY,
a difucosylated carbohydrate antigen, is overexpressed by a variety of cancer cell
types.;